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Abstract 
BACKGROUND: Hepatic encephalopathy is a serious complication of cirrhosis that presents with a variety of 
neuropsychiatric abnormalities, including disorientation, asterixis, and coma. Seizures are an uncommon and 
potentially dangerous complication of hepatic encephalopathy. We present a unique case of a 42-year-old female 
with a history of well-controlled seizure disorder suddenly become refractory to anticonvulsant therapy following 
the development of hepatic encephalopathy secondary to liver decompensation. 
CASE PRESENTATION: A 42-year-old female presented to our hospital following a seizure accompanied by loss 
of consciousness, urinary incontinence, and the prolonged postictal state. She reports her seizures were initially 
well-controlled with Levetiracetam 500 mg twice a day but recently began experiencing seizures every other day 
despite up-titration of Levetiracetam to 1500 mg twice a day over a few weeks. On arrival, her serum ammonia 
level was 116 μmol/L. CT brain was negative while CT liver was consistent with cirrhotic morphology. An 
electroencephalogram revealed irregular, diffuse, delta/theta slowing consistent with mild to moderate 
encephalopathy. The patient was started on lactulose 40mg and Rifaximin 550 mg twice a day. Her symptoms of 
disorientation and lethargy resolved over 3 days.  
CONCLUSION: Though uncommon, hepatic encephalopathy should be considered in patients presenting with 
convulsions, especially if there is a known history of liver disease. Until the underlying liver issues are addressed, 
patients may not respond to traditional anti-convulsant therapy for their seizures. 
 
 
 
 
 
 
 
Introduction 
 
Around 30 to 45% of patients with cirrhosis 
develop hepatic encephalopathy (HE), and this 
development has been associated with a poor 
prognosis [1]. HE is a serious complication of cirrhosis 
and portosystemic shunts that presents with a 
spectrum of neuropsychiatric abnormalities, ranging 
from disorientation to coma, that can greatly debilitate 
patients’ lives. Abnormal motor symptoms such as 
irregular tremor and asterixis are also frequently 
associated with the disorder [2], [3], [4], [5]. Seizures 
are uncommon yet potentially dangerous 
complications of HE [3], [6], [7].  
 
Case Presentation 
 
A 42-year-old female with a history of 
cirrhosis secondary to chronic hepatitis B virus 
infection was brought to our emergency department 
following a seizure accompanied by loss of 
consciousness and urinary incontinence. She reports 
a history of seizures that began 5 months prior when 
she was admitted to a different hospital for HBV 
cirrhosis and abdominal pain. During that hospital 
stay, the patient was given Tramadol, which she 
attributes the onset of her seizures too. The seizures 
were initially controlled with Levetiracetam 500 mg 
twice a day; however patient states that seizures have 
increased in frequency to every other day over the 
past few weeks despite up-titration of Levetiracetam 
to 1500 mg twice a day. Her other medications at the 
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time include Tenofovir 300 mg daily for her HBV 
infection and propranolol 10 mg twice a day and 
pantoprazole 20 mg daily for portosystemic varices 
seen on prior CT imaging. She also reports 
intermittent lower extremity oedema which she takes 
Furosemide 20 mg daily. She usually does not go to 
the ED when she has a seizure. However, she 
presented to our ED because her seizures have 
increased in frequency and been accompanied by 
prolonged post-ictal states. Per discussion with family, 
the patient had had increasingly slower mentation 
since the initial admission 5 months ago. Patient 
reports feeling more lethargic and “off” for the past few 
weeks.  
Vitals on admission were a blood pressure of 
139/97, the pulse of 93 beats/minute, and SpO2 of 
99% on room air. On clinical exam, the patient was 
somnolent and slow to answer questions. She was 
alert and oriented to person and place but not time. 
Scleral icterus, asterixis, and mild upper abdominal 
pain were present. There were diminished vibration 
and position sense in the lower extremities bilaterally. 
There was no ascites or oedema. Heart sounds were 
normal, and the lungs were clear to auscultation. 
Laboratory studies showed a white blood cell 
count of 4500/mm
3
, haemoglobin of 12.1 g/dL, 
hematocrit of 37.9%, and platelets of 112000/mm
3
. 
Electrolytes were normal. Other labs include: total 
protein of 7.3 mg/dL, total bilirubin of 3.8 mg/dL, 
albumin of 2.6 g/dL, aspartate aminotransferase of 
98IU/L, alanine aminotransferase of 71IU/L, alkaline 
phosphatase of 275IU/L, and ammonia of 116mol/L 
(reference range 9 mol/L-33 mol/L). Prothrombin 
time was 20.6 seconds, and INR was 1.79. CT brain 
was without evidence of acute bleed or mass effect 
while CT liver was consistent with hepatic cirrhotic 
morphology. An electroencephalogram revealed 
findings consistent with mild to moderate 
encephalopathy (Figure 1). The patient denied the 
prior history of hepatic encephalopathy. 
 
Figure 1: Electroencephalogram showing irregular, diffuse, 
delta/theta slowing consistent with mild to moderate 
encephalopathy 
 
Based on the laboratory, imaging, and clinical 
findings, her altered mental status and seizures 
refractory to anticonvulsant therapy were attributed to 
hepatic encephalopathy secondary to liver 
decompensation from HBV cirrhosis. The patient was 
started on lactulose 40 mg twice a day, titrated to 2-3 
bowel movements daily and Rifaximin 550 mg twice a 
day. Over 3 days, her mental status improved, she 
was no longer lethargic, and her scleral icterus and 
asterixis resolved. She was discharged on the fourth 
hospital day with her home medication and lactulose 
for further management of her hepatic 
encephalopathy. She has not experienced another 
seizure on 3 months follow up and continues to do 
well. 
 
 
Discussion 
 
Hepatic encephalopathy (HE) is a reversible 
consequence of advanced liver disease and/or 
portosystemic shunting characterised by impaired 
neurologic function including altered mental status, 
asterixis, and possible coma [2], [3], [4], [5]. The 
frequency of seizures in HE remains uncertain. One 
study found that up to one-third of their patients with 
HE developed seizures; however, this was largely in 
more advanced disease stages [8]. Other authors 
suggest seizures are an uncommon event [3], [6], [7]. 
Ficker et al. reviewed EEG tracings in patients with 
HE and found that when epileptiform abnormalities 
were present, they were associated with a poorer 
prognosis [6].  
The pathophysiology of HE is multifactorial 
and complex, including changes in ammonia (NH3) 
levels, inflammatory cytokines, and amino acids [2], 
[4], [7]. The most widely understood mechanism 
involves the hepatic metabolism of NH3. The 2 primary 
metabolic pathways by which ammonia is handled is 
through the urea cycle and glutamine synthase 
(produces glutamine from glutamate) [4]. In patients 
with cirrhosis, there is hepatocellular dysfunction and 
portosystemic shunting, resulting in increased levels 
of ammonia through the systemic circulation. 
Astrocytes in the brain convert NH3 and glutamate to 
glutamine. Hyperammonemia results in increased 
glutamine production and accumulation in astrocytes 
creating an osmotic gradient that promotes astrocytic 
swelling [2], [4], [7]. Elevated glutamine levels also 
result in the generation of reactive oxygen species 
through a process of hydrolysis in mitochondria, which 
contributes to the neuronal dysfunction in hepatic 
encephalopathy. A milieu of inflammatory cytokines 
augment the neurotoxic effects of ammonia by 
enhancing the diffusion of ammonia across the blood-
brain barrier in addition to exerting their neurotoxic 
effects [4]. 
EEG recordings have been useful in 
identifying the underlying aetiology of altered mental 
status in patients with liver cirrhosis. A few reports 
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detail the use of EEG recordings to discern hepatic 
encephalopathy from conditions such as 
nonconvulsive status epilepticus (NCSE), which can 
be hidden within a diagnosis of HE yet requires a 
different course of medical management [9], [10], [11]. 
While other cases of status epilepticus secondary to 
HE have been reported [3], [12], [13], our case 
demonstrates a patient who initially had a history of 
seizures well-controlled with anti-convulsants, and no 
prior history of HE, suddenly become refractory to her 
medication. Her decompensated liver state 
aggravated her neurological issues, which prompted 
further medical management of her condition beyond 
regular anti-convulsant therapy. The addition of 
lactuolose and Rifaximin produced a clinically 
significant resolution of symptoms in our patient. 
Therefore, although rare, it is important to appreciate 
HE as an exacerbating factor in convulsive patients 
because the therapeutic management of these 
patients may change. Furthermore, certain anti-
epileptic drugs, such as benzodiazepines, can 
potentially worsen HE, so it is imperative that a 
diagnosis of HE is not overlooked in convulsive 
patients [2], [3].  
In conclusion, seizures are an uncommon and 
potentially serious complication in patients with 
hepatic encephalopathy. EEG recordings may be 
useful in ruling out other etiologies of altered mental 
status in patients with a history of liver disease 
presenting with convulsions. Patients experiencing 
seizures secondary to HE may not respond to 
traditional anti-convulsant therapy, and therefore, the 
underlying liver problems must be addressed.  
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